Targeting NK cells for anti-cancer immunotherapy: clinical and pre-clinical approaches
The recent success of checkpoint blockade has highlighted the potential of immunotherapy approaches for cancer treatment. While the majority of approved immunotherapy drugs target T cell subsets, it is appreciated that other components of the immune system have important roles in tumor immune-survei...
Main Author: | Sebastian eCarotta |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00152/full |
Similar Items
-
Editorial: Tailoring NK Cell Receptor–Ligand Interactions: An Art in Evolution
by: Ulrike Koehl, et al.
Published: (2018-02-01) -
Regulation of Murine Natural Killer Cell Commitment
by: Nicholas D Huntington, et al.
Published: (2013-01-01) -
Harnessing NK Cell Checkpoint-Modulating Immunotherapies
by: Sachin Kumar Singh Chauhan, et al.
Published: (2020-07-01) -
NK Cell-Based Immune Checkpoint Inhibition
by: Muhammad Khan, et al.
Published: (2020-02-01) -
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
by: Simona Sivori, et al.
Published: (2020-09-01)